TapImmune Inc Email Format

Biotechnology ResearchFlorida, United States0-1 Employees

TapImmune Inc is a biotechnology research company focused on developing cancer immunotherapies, including T-cell vaccine approaches intended to address tumors and metastatic disease. It is advancing two clinical-stage T-cell vaccine candidates in multiple Phase II and Phase Ib/IIa trials for ovarian and breast cancers, with programs that could qualify for FDA Fast Track and Orphan Drug Designations. The company describes its off-the-shelf vaccines as designed to stimulate both killer and helper T-cells to attack cancer cells and to be effective across a broad portion of the population. TapImmune collaborates with other organizations, including Mayo Clinic, Memorial Sloan Kettering Cancer Center, and AstraZeneca. Headquartered in Jacksonville, Florida, the company has a very small workforce (0-1 employees); in 2018 it merged with Marker Therapeutics to form a new entity that included a strategic alliance with Baylor College of Medicine.

Get verified TapImmune Inc emails free

Company overview Employee directory